|
ZNF420 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.91617857534266E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.83070242193639E-11 |
| Normal-vs-Stage2 |
9.7814000010743E-08 |
| Normal-vs-Stage3 |
5.65880675651442E-13 |
| Normal-vs-Stage4 |
1.62803104331033E-12 |
| Stage1-vs-Stage2 |
3.467200E-01 |
| Stage1-vs-Stage3 |
5.050300E-02 |
| Stage1-vs-Stage4 |
1.027010E-04 |
| Stage2-vs-Stage3 |
2.855700E-02 |
| Stage2-vs-Stage4 |
7.226300E-04 |
| Stage3-vs-Stage4 |
7.457700E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.13862261233544E-12 |
| Normal-vs-AfricanAmerican |
7.82389997233679E-09 |
| Normal-vs-Asian |
2.18269957663608E-10 |
| Caucasian-vs-AfricanAmerican |
8.846000E-01 |
| Caucasian-vs-Asian |
7.345200E-01 |
| AfricanAmerican-vs-Asian |
7.150800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.49482681577729E-12 |
| Normal-vs-Female |
8.5087492607272E-12 |
| Male-vs-Female |
6.377400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.55879761823508E-11 |
| Normal-vs-Age(41-60Yrs) |
7.32536253877925E-12 |
| Normal-vs-Age(61-80Yrs) |
4.82636153265048E-12 |
| Normal-vs-Age(81-100Yrs) |
2.720200E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.386200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.021800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.804400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.667800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.212800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.675800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.38520000000109E-05 |
| Classical-VS-Follicular |
1.250050E-01 |
| Classical-VS-Other |
7.001000E-01 |
| Classical-VS-Normal |
3.38979955216701E-11 |
| Tall-VS-Follicular |
1.73005999999365E-05 |
| Tall-VS-Other |
3.543600E-01 |
| Tall-VS-Normal |
1.62792002100787E-12 |
| Follicular-VS-Other |
4.303800E-01 |
| Follicular-VS-Normal |
2.57370003087232E-09 |
| Other-VS-Normal |
1.781180E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.30879792851147E-11 |
| Normal-vs-N1 |
2.44249065417534E-14 |
| N0-vs-N1 |
3.240000E-03 |
|
|
